Bill Snyder

January 24, 2017

Saliva test for obesity risk

“Epigenetic signatures” in DNA may present an opportunity for prevention of or early intervention in childhood obesity.

By Bill Snyder
Close-up of a woolen knitted texture (blue)
January 19, 2017

Surprising finding by VU team sheds light on fibrotic disease

Integrins are membrane proteins made up of combinations of different “alpha” and “beta” subunits that enable cells throughout the body to interact with their surroundings.

By Bill Snyder
January 19, 2017

COX-2 ‘conjugate’ may slow growth of some tumors: study

More than a decade after the anti-inflammatory drugs Vioxx and Bextra were pulled from the market because of a heightened risk of heart attack and stroke in some patients, COX-2 inhibitors may be on the verge of a comeback, this time as anti-cancer agents.

By Bill Snyder
Hand completing a multiple choice exam. The answer form was created by me and is not copyrighted.
January 19, 2017

GRE may be poor predictor of science success: study

Since it was created in 1949, the Graduate Record Exam (GRE) has been one of the most widely used requirements for admission to U.S. graduate schools. As a predictor of performance and success in graduate school, however, the exam is not without its critics.

By Bill Snyder
January 19, 2017

Amount of daylight may impact serotonin programming

The duration of exposure to daylight, or the “photoperiod,” may affect development of seasonal affective disorder by programming serotonin neurons in the brain, according to Vanderbilt University researchers.

By Bill Snyder
January 17, 2017

A heart-brain connection

Cognitive and attention deficits observed in children following surgery before age 5 to repair congenital heart defects likely will persist into their teens and young adulthood.

By Bill Snyder
January 12, 2017

Lindsley’s drug discovery efforts land ASPET Award

Craig Lindsley, Ph.D., a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is the 2017 recipient of the Pharmacia-ASPET Award in Experimental Therapeutics from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
By Bill Snyder
January 12, 2017

Team’s discovery offers new insight on lung cancer risk

Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts.
By Bill Snyder
January 12, 2017

Nominations sought for Vanderbilt Prize in Biomedical Science

Nominations for the 2017 Vanderbilt Prize in Biomedical Science are now being accepted. The deadline is March 31.
By Bill Snyder
January 5, 2017

Department of Medicine’s NIH funding swells

Vanderbilt University School of Medicine has long been recognized as a national leader in biomedical research. Nowhere is this more evident than in the school’s Department of Medicine, which, during the 2016 federal fiscal year that ended Sept. 30, broke another record.
By Bill Snyder
December 21, 2016

Daughter’s rare adverse drug reaction inspires family’s donation

Last year Paul and Wanpen Anderson of Champaign, Illinois, were preparing to celebrate the Christmas holidays with their two children when their 22-year-old daughter, Angela, developed a rare adverse drug reaction called SJS/TEN.
By Bill Snyder
December 15, 2016

New clues emerge in rare form of childhood epilepsy

Researchers at Vanderbilt University Medical Center (VUMC) are one step closer to understanding what causes early-onset epileptic encephalopathy, a rare form of childhood epilepsy that is difficult to treat and has poor developmental outcomes.
By Bill Snyder
1 … 69 70 71 72 73 … 115